ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) was up 0.8% during trading on Friday . The stock traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares traded hands during trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Up 0.8 %
The company has a market capitalization of C$162.08 million and a price-to-earnings ratio of -7.30. The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06. The business’s 50 day moving average is C$6.50 and its 200 day moving average is C$6.50.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- Energy and Oil Stocks Explained
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Top-Performing Non-Leveraged ETFs This Year
- Insider Trades May Not Tell You What You Think
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
